(UTI) |
| 0 (0%) 10-12 13:48 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 26.43 |
| Resistance 1: | 22.63 |
| Pivot price: | 19.76 |
| Support 1: | 19.78 |
| Support 2: | 18.02 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.610 |
| Book Value | 6.250 |
| PEG Ratio | 1.81 |
| Gross Profit | 8.828 |
| Profit Margin (%) | 3.88 |
| Operating Margin (%) | 1.99 |
| Return on Assets (ttm) | 3.5 |
| Return on Equity (ttm) | 10.5 |
Company news
Mon, 12 Oct 2026
Making the Case for Early IV-to-Oral Transition in Complicated UTI - The American Journal of Managed Care
Mon, 12 Oct 2026
Phage Therapy Trials Are Launching Without a Regulatory Playbook. That’s a Problem. - The Clinical Trial Vanguard
Sat, 10 Oct 2026
How Investors May Respond To UTI Stock Faster Concorde Expansion - Simply Wall Street
Fri, 09 Oct 2026
Bladder cancer mistaken for UTI, perimenopause in women - ABC News & Headlines – Australian Broadcasting Corporation
Fri, 09 Oct 2026
New UTI Guidelines: Addressing the Shift to Localized, Systemic Infection Classification - Contagion Live
Fri, 09 Oct 2026
103 U.S. drilling rigs operated on average for Patterson-UTI in September; its three-month average was 101. - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
